Child Neurology·Wilmington, DE

Sidney Kimmel Medical College at Thomas Jefferson University/Nemours Children's Health, Wilmington

Signal lift67%89%+22 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
229–262
p10 – p90
Sample N
108
applicants this cycle
This cycle
no tracked aways yet
Match rate
1.9%
2 of 50 applicants
01Cohort funnelthis cycle
N = 108
Applied
108
100.0%
Invited
50
46.3%
Class size
2
1.9%
J-1 visaH-1B visaCategorical
Your fitSidney Kimmel Medical College at Thomas Jefferson University/Nemours Children's Health, Wilmington Program

Create a free profile to see your personalized fit

Get started
Contact
BW
Program Director
Brian F White, MD
Email director
JH
Program Coordinator
Jennifer Hultberg, MD
Email coordinator
Training sites2 hospitals
  • 1
    Nemours Children's Health Wilmington
    Wilmington, DE
    Primary
  • 2
    Sidney Kimmel Medical College at Thomas Jefferson University
    Philadelphia, PA
    Sponsor
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK229262
180205230255280

Level 2 CE data not available

Interview rates
US MD
79%
US DO
90%
US IMG
7%
Non-US IMG
0%
Applicant origin
In-state
0%
Out-of-state
46%
Interview prepChild Neurology
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesChild Neurology · 25-26
Save this program

Add Sidney Kimmel Medical College at Thomas Jefferson University/Nemours Children's Health, Wilmington to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Child Neurology.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.